ABL Bio Inc
KOSDAQ:298380
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
ABL Bio Inc
KOSDAQ:298380
|
KR |
|
ING Groep NV
AEX:INGA
|
NL |
|
S
|
Sandvik AB
OTC:SDVKY
|
SE |
|
Advanced Info Service PCL
SET:ADVANC
|
TH |
|
Interglobe Aviation Ltd
NSE:INDIGO
|
IN |
|
B
|
Boston Scientific Corp
DUS:BSX
|
US |
|
A
|
A2A SpA
F:EAM
|
IT |
|
I
|
Invesco Ltd
SWB:3IW
|
US |
|
Wal Mart de Mexico SAB de CV
F:4GNB
|
MX |
|
H
|
Hercules Capital Inc
F:19H
|
US |
|
K
|
Kuaishou Technology
OTC:KSHTY
|
CN |
|
Associated British Foods PLC
F:AFO2
|
UK |
|
Severn Trent PLC
F:SVT
|
UK |
|
Stora Enso Oyj
F:ENUS
|
FI |
|
C
|
Cotana Group JSC
VN:CSC
|
VN |
|
E
|
EnChem Co Ltd
KOSDAQ:348370
|
KR |
|
D
|
DSV A/S
XMUN:DS81
|
DK |
|
O
|
ODTech
KOSDAQ:080520
|
KR |
|
Les Hotels de Paris SA
PAR:HDP
|
FR |
|
Hansen Technologies Ltd
ASX:HSN
|
AU |
|
M
|
Myriad Genetics Inc
F:MYD
|
US |
|
K
|
Krungthai Card PCL
SET:KTC
|
TH |
|
LNA Sante SA
F:2N3
|
FR |
|
Kurashiru Inc
TSE:299A
|
JP |
Bankruptcy Probability
ABL Bio Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
ABL Bio Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| KR |
A
|
ABL Bio Inc
KOSDAQ:298380
|
2.8T KRW |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
AbbVie Inc
NYSE:ABBV
|
468.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
219.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences, Inc
NASDAQ:GILD
|
185.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
132.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
82.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
77.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
52.9B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
84.7B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Natera Inc
NASDAQ:NTRA
|
58.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Revolution Medicines Inc
NASDAQ:RVMD
|
42.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
ABL Bio Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, ABL Bio Inc has total debt of 213.4m KRW. This includes both short-term (0 KRW) and long-term (213.4m KRW) debt.
You can find a full breakdown on its Balance Sheet.